Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-04-11 00:00:00 ET · period of report 2025-04-11 · accession 0001415889-25-010574 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-11 | 2025-04-11 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $4.95 | -1,409 | 53.8K | -3% | -$6,975 |
| D | 2025-04-11 | 2025-04-11 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.30 | +2,173 | 55.2K | +4% | +$4,998 |
| D | 2025-04-11 | 2025-04-11 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.30 | -2,173 | 180.5K | -1% | -$4,998 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-04-11 | S | D | 1,409 | $4.95 | 53,784 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 2 | Common | Common Shares | 2025-04-11 | M | A | 2,173 | $2.30 | 55,193 | D | — | — | (F1) . Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023. |
| 3 | Derivative | Common Shares | 2025-04-11 | M | D | 2,173 | $2.30 | 180,533 | D | $2.30 · 2015-05-11 to 2025-05-11 | 2,173 Options | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023. |